Advertisement
NEXGEL, Inc.

NEXGEL, Inc. Fundamental Analysis

NXGLNASDAQ
HealthcareMedical - Instruments & Supplies
$0.56
$0.009(1.69%)
U.S. Market is Open · 12:19
Advertisement

NEXGEL, Inc. Fundamental Analysis

NEXGEL, Inc. (NXGL) shows weak financial fundamentals with a PE ratio of -1.44, profit margin of -28.54%, and ROE of -70.23%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.11
Current Ratio1.70

Areas of Concern

ROE-70.23%
Operating Margin-31.37%
Cash Position4.36%
We analyze NXGL's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -92.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-92.3/100

We analyze NXGL's fundamental strength across five key dimensions:

Efficiency Score

Weak

NXGL struggles to generate sufficient returns from assets.

ROA > 10%
-27.72%

Valuation Score

Excellent

NXGL trades at attractive valuation levels.

PE < 25
-1.44
PEG Ratio < 2
-0.11

Growth Score

Weak

NXGL faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

NXGL shows balanced financial health with some risks.

Debt/Equity < 1
1.05
Current Ratio > 1
1.70

Profitability Score

Weak

NXGL struggles to sustain strong margins.

ROE > 15%
-7023.48%
Net Margin ≥ 15%
-28.54%
Positive Free Cash Flow
No

Key Financial Metrics

Is NXGL Expensive or Cheap?

P/E Ratio

NXGL trades at -1.44 times earnings. This suggests potential undervaluation.

-1.44

PEG Ratio

When adjusting for growth, NXGL's PEG of -0.11 indicates potential undervaluation.

-0.11

Price to Book

The market values NEXGEL, Inc. at 1.16 times its book value. This may indicate undervaluation.

1.16

EV/EBITDA

Enterprise value stands at -0.41 times EBITDA. This is generally considered low.

-0.41

How Well Does NXGL Make Money?

Net Profit Margin

For every $100 in sales, NEXGEL, Inc. keeps $-28.54 as profit after all expenses.

-28.54%

Operating Margin

Core operations generate -31.37 in profit for every $100 in revenue, before interest and taxes.

-31.37%

ROE

Management delivers $-70.23 in profit for every $100 of shareholder equity.

-70.23%

ROA

NEXGEL, Inc. generates $-27.72 in profit for every $100 in assets, demonstrating efficient asset deployment.

-27.72%

Following the Money - Real Cash Generation

Operating Cash Flow

NEXGEL, Inc. generates limited operating cash flow of $-1.57M, signaling weaker underlying cash strength.

$-1.57M

Free Cash Flow

NEXGEL, Inc. generates weak or negative free cash flow of $-1.58M, restricting financial flexibility.

$-1.58M

FCF Per Share

Each share generates $-0.17 in free cash annually.

$-0.17

FCF Yield

NXGL converts -27.55% of its market value into free cash.

-27.55%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.44

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.46

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.70

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.70

vs 25 benchmark

ROA

Return on assets percentage

-0.28

vs 25 benchmark

ROCE

Return on capital employed

-0.43

vs 25 benchmark

How NXGL Stacks Against Its Sector Peers

MetricNXGL ValueSector AveragePerformance
P/E Ratio-1.4434.27 Better (Cheaper)
ROE-70.23%377.00% Weak
Net Margin-28.54%-42945.00% (disorted) Weak
Debt/Equity1.050.78 Weak (High Leverage)
Current Ratio1.705.54 Neutral
ROA-27.72%-162.00% (disorted) Weak

NXGL outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews NEXGEL, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ